Recombinant adenovirus type 5 HIV gag/pol/nef vaccine in South Africa: unblinded, long-term follow-up of the phase 2b HVTN 503/Phambili study.
Saved in:
| Title: | Recombinant adenovirus type 5 HIV gag/pol/nef vaccine in South Africa: unblinded, long-term follow-up of the phase 2b HVTN 503/Phambili study. |
|---|---|
| Authors: | Gray GE; Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa; South African Medical Research Council, Cape Town, South Africa. Electronic address: gray@pixie.co.za., Moodie Z; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Metch B; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Gilbert PB; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Bekker LG; Desmond Tutu HIV Foundation, University of Cape Town, Cape Town, South Africa., Churchyard G; Aurum Institute for Health Research, Johannesburg, South Africa., Nchabeleng M; MEDUNSA HIV Clinical Research Unit, University of Limpopo, Mankweng-E, South Africa., Mlisana K; Centre for AIDS Programme for Research in South Africa, University of KwaZulu-Natal, Durban, South Africa., Laher F; Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa., Roux S; Desmond Tutu HIV Foundation, University of Cape Town, Cape Town, South Africa., Mngadi K; Centre for AIDS Programme for Research in South Africa, University of KwaZulu-Natal, Durban, South Africa., Innes C; Aurum Institute for Health Research, Johannesburg, South Africa., Mathebula M; MEDUNSA HIV Clinical Research Unit, University of Limpopo, Mankweng-E, South Africa., Allen M; Vaccine Research Program, Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., McElrath MJ; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Robertson M; Infectious Diseases and Vaccines Clinical Research, Merck and Company, North Wales, PA, USA., Kublin J; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Corey L; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. |
| Corporate Authors: | HVTN 503/Phambili study team |
| Source: | The Lancet. Infectious diseases [Lancet Infect Dis] 2014 May; Vol. 14 (5), pp. 388-96. Date of Electronic Publication: 2014 Feb 20. |
| Publication Type: | Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Science Country of Publication: United States NLM ID: 101130150 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-4457 (Electronic) Linking ISSN: 14733099 NLM ISO Abbreviation: Lancet Infect Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
